Sleep disorders of insomnia type in patients with amyotrophic lateral sclerosis
https://doi.org/10.17650/2222-8721-2017-7-3-43-46
Abstract
Objective: to evaluate the rate of sleep disorders of insomnia type among patients with amyotrophic lateral sclerosis (ALS) and to study the connection between these disorders and clinical characteristics of the disease. Materials and methods. The study included 101 patients (50 men and 51 women) with confirmed ALS diagnosis; mean age was 58.9 ± 9.6 years. The patient data was evaluated using the ALS Functional Rating Scale Respiratory (ALSFRS-R), Hamilton Depression Rating Scale, and ALS-specific Quality of Life Scale. Results. Sleep disorders were observed in 77 (76.3 %) ALS patients, among whom slow progression was more common (χ2 criterion 3.2; р = 0.048), quality of life was significantly lower (t = –2.043; p = 0.044), and total score per the Hamilton Depression Rating Scale was significantly higher (t = –3.98; р = 0.0001). Patients were divided into 3 groups: The 1st group included patients with primarily motor disorders, the 2nd group included patients with pronounced emotional depressive disorders without severe motor disorders, and the 3rd group included patients with both factors but duration of the disease was longer than in the 2nd group. The rate of postsomniac disorders was significantly higher in the 2nd group than in the 1st group (p = 0.022), and combination of presomniac, intrasomniac, and postsomniac disorders was significantly higher in the 3rd group than in the 1st (р = 0.007). Conclusions. Sleep disorders associated with ALS are accompanied by various complaints (presomniac, intrasomniac, postsomniac, or their combinations) depending on the severity of motor or emotional disorders in these patients.
About the Authors
G. N. Levitskiy
Russian Amyotrophic Lateral Sclerosis Charity Foundation;
Clinical Diagnostic Center “Real Health”
Russian Federation
Russian Federation
M. G. Poluektov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Russian Federation
Department of Neurological Diseases
Russian Federation
Department of Neurological Diseases
References
1. Louveau A., Plog B. A., Antila S. et al. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Invest 2017;127(9):3210–19. DOI: 10.1172/ JCI90603. PMID: 28862640.
2. Xie L., Kang H., Xu Q. et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342(6156):373–7. DOI: 10.1126/ science.1241224. PMID: 24136970.
3. Radunovic A., Annane D., Jewitt K., Mustfa N. Mechanical ventilation
4. for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2009;(4):CD004427. DOI: 10.1002/14651858.CD004427.pub2. PMID: 19821325.
5. Полуэктов М. Г., Левин Я. И., Левицкий Г. Н. и др. Расстройства дыхания
6. во сне при болезни двигательного нейрона. Журнал неврологии и психиатрии им. С. С. Корсакова 2005;105(10):4–9. [Poluektov M. G., Levin Ya. I.,
7. Levitskiy G.N. et al. Sleep-related breathing disturbances in motor neuron disease. Zhurnal nevrologii i psikhiatrii im. S. S. Korsakova = S. S. Korsakov Journal of Neurology and Psychiatry 2005;105(10): 4–9. (In Russ.)]. PMID:16281372.
8. Gozal E., Sachleben L. R. Jr, Rane M. J. et al. Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 2005;288(3):535–42. DOI: 10.1152/ajpcell.00270.2004. PMID: 15537711.
9. Xu J., Nolan M. T., Heinze K. et al. Symptom frequency, severity, and quality of life among persons with three disease trajectories: cancer, ALS, and CHF. Appl Nurs Res 2015;28(4):311–5. DOI: 10.1016/j.apnr.2015.03.005. PMID: 26608431.
10. Ahmed R. M., Newcombe R. E., Piper A. J. et al. Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev 2016;26:33–42. DOI: 10.1016/j.smrv.2015.05.007. PMID: 26166297.
11. Brooks B. R., Miller R. G., Swash M. et al. El Escorial revisted: revised criteria
12. for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293–9. PMID: 11464847.
13. Cedarbaum J. M., Stambler N., Malta E. et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessment of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999;169(1–2):13–21. PMID: 10540002.
14. Jenkinson C., Fitzpatrick R., Swash M., Levvy G. ALSAQ User Manual. Hogan Print Partnership, Oxford, 2000. 112 p.
15. Sim M., Reid D., Pallett J., Gordon E. The Hamilton rating scale. An assessment bases on a dothiepin (“rothiaden”) versus imipramine (“Tofranil”) clinical trial. Int Pharmacopsychiatry 1975;10(3):142–8. PMID:1099046.
16. Lo Coco D., La Bella V. Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 2012;19(5):760–3. DOI: 10.1111/j.1468- 1331.2011.03637.x. PMID: 22233269.
17. Голенков А. В., Полуэктов М. Г. Особенности и нарушения сна в пожилом и старческом возрасте. Клиническая геронтология 2012;(7–8):8–13. [Golenkov A. V., Poluektov M. G. Features and disorders of sleep in elderly and senile patients. Klinicheskaya gerontologiya = Clinical Gerontology 2012;(7–8):8–13. (In Russ.)].
18. Голенков А. В. Нарушения сна и психическая патология. В кн.: Сомнология и медицина сна: национальное руководство памяти А. М. Вейна
19. и Я. И. Левина. Под ред. М. Г. Полуэктова. М.: Медфорум, 2016. C. 508–523. [Golenkov A. V. Sleep disorders and psychiatric pathology. In book: Somnology and medicine of sleep: National guidelines in the memory of A. M. Veyn and
20. Ya. I. Levin. Ed. M.G. Poluektov. Moscow: Medforum, 2016. Pp. 508–523. (In Russ.)].
Review
For citations:
Levitskiy G.N., Poluektov M.G. Sleep disorders of insomnia type in patients with amyotrophic lateral sclerosis. Neuromuscular Diseases. 2017;7(3):43-46. (In Russ.) https://doi.org/10.17650/2222-8721-2017-7-3-43-46
Views:
1042
Email this article 